Skip to main content

Inside the world of cell therapies

While uptake has been limited, cell therapy's impact in cancer care is growing, and biotech companies have continued to invest in ways to improve it, such as through "off-the-shelf" options. Discover the current market for cancer cell therapies and what biotechs are working on next.

included in this trendline
  • CAR-T treatment moves earlier as FDA widens approval of Gilead’s Yescarta
  • J&J, Legend cell therapy approved by FDA for multiple myeloma
  • Versant-backed startup launches with plans to broaden cell therapy’s reach
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.